GE HealthCare Is Going Independent. This Is Where the Stock Should Trade.

Text size GE HealthCare should generate about $3.3 billion in Ebitda for all of 2022. Kamil Krzaczynski/Getty Images To start 2023, investors will have a choice to invest in a brand new $18 billion co...

Horizon Therapeutics, Coupa Software, Rivian, and More Stock Market Movers

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Novozymes and Chr. Hansen agree deal to merge

Danish biotechnology companies Novozymes AS NZYM.B, -13.67% and Chr. Hansen Holding AS CHR, +23.64% said Monday they have agreed to merge, creating a biological solutions provider with combined annual...

Paccar, Deere, and 10 More Companies That Raised Their Stock Dividends This Week

Text size Paccar said it will boost its regular dividend to 25 cents a share. Dreamstime Carrier Global, Deere , Zoetis , and Paccar were among the many large U.S. companies that declared dividend inc...

CVS Wants to Be a Healthcare Provider. So Why Doesn’t It Have Any Doctors?

Late last year, CVS Health CEO Karen Lynch unveiled a new strategy: Rather than remain simply a pit stop for toilet paper and flu shots, CVS stores would become a place that Americans—particularly old...

GE Healthcare Plans to Reduce Debt and Costs, Pursue Tuck-In Acquisitions

General Electric Co.’s healthcare division plans to cut debt, bring down costs and pursue tuck-in acquisitions after its spinoff in early January, finance chief Helmut Zodl said Thursday at an investo...

BNP Paribas studied 100 years of market crashes — here’s what it says is coming next

Oops. Stocks fell through a key support on Tuesday and it looks like some recent momentum has now petered out. The new line in the sand for the S&P 500 SPX, -1.44% seems to be 3,900. Whether Santa...

10 Dividend Aristocrat stocks expected by analysts to rise up to 54% in 2023

Stocks of companies that raise dividends consistently have outperformed during this year’s bear market. Below is a screen showing which stocks are analysts’ favorites for next year among an expanded l...

McCormick, PulteGroup, and Merck Boost Dividends

McCormick PulteGroup and Merck Merck were among the large U.S. companies that declared dividend increases this week. McCormick (ticker:MKC) will boost its quarterly disbursement to 39 cents a share fr...

Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.

Sometimes, a single worry grows so large that it obscures all the good things happening at the same time. That’s the case with the stock of pharma giant AbbVie whose blockbuster drug Humira faces pate...

Elizabeth Holmes Sentencing: A History of the WSJ Theranos Investigation

By Michael Siconolfi Nov. 18, 2022 5:30 am ET Listen to article (2 minutes) Elizabeth Holmes’s journey from Silicon Valley superstar to felon is slated to culminate Friday during a hearing in which a ...

18 semiconductor stocks that shine when compared with Nvidia this earnings season

Nvidia Corp., which said yesterday that quarterly sales slumped, exemplifies the cyclical nature of the semiconductor industry despite the company’s inroads into fast-growing markets. Still, many chip...

Sunrun and Other Solar Stocks With Strong U.S. Presence Are a Buy, Analyst Says

An analyst from Deutsche Bank is bullish on Enphase Energy Sunrun and First Solar due to their strong domestic presence amid new U.S. legislation. Deutsche Bank analyst Corinne Blanchard initiated cov...

D.R. Horton and 7 More Companies That Raised Their Stock Dividends

Text size D.R. Horton plans to boost its quarterly payout by 11% to 25 cents a share. Caitlin O’Hara/Bloomberg It was a busy week for dividend increases among large U.S. companies across a varie...

FTX’s stunning collapse nothing like Theranos, says venture investor and crypto bull Tim Draper

Tim Draper, founder and managing partner of Draper Associates and Draper University, balked at comparing the stunning implosion of crypto trading platform FTX to the notorious biotech startup Theranos...

Big Pharma Stocks Are Breaking Out. Here Are Some Winners.

Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs.   These stocks had been outpe...

Twitter Is Elon Musk’s Biggest Test—and Tesla’s Biggest Challenge. How They’ll Make It Work.

Elon Musk officially owns Twitter—and now the hand-wringing about his ability to oversee the rest of his empire has begun again. Of all the concerns around Tesla however, Musk’s ability to manage his ...

Pfizer Stock’s Post-Covid Future Looks Healthy

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say

The AARP name has become a marketing juggernaut among baby boomers, with the group’s nearly 38 million members receiving offers for AARP-branded health, life and auto insurance, and discounts on cellp...

20 dividend stocks that may be safest if the Federal Reserve causes a recession

Investors cheered when a report last week showed the economy expanded in the third quarter after back-to-back contractions. But it’s too early to get excited, because the Federal Reserve hasn’t given ...

Pfizer’s Earnings Are Tuesday. What to Watch.

Pfizer is set to report its earnings on Tuesday, a week and a half after an executive told investors that the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per...

AbbVie Stock Slips as Sales Miss Expectations And Bigger Challenges Await.

Stock in AbbVie slipped after the drug company reported a higher profit than expected, while sales fell short. The revenue shortfall may have reminded investors of a challenge AbbVie (ticker: ABBV) fa...

Medtronic Is Doing a Spinoff. What It Means for Our Stock Pick.

Medical device maker Medtronic is spinning off two business units to try to drive higher growth. The market isn’t impressed.  In theory, it should be. Spinoffs are supposed to streamline operations of...

20-year-old investor who made $110 million on a meme stock is now pushing for change at psychedelics company MindMed

The 20-year-old investor who found fame this year when he made $110 million trading shares of troubled retailer Bed Bath & Beyond Inc. BBBY, -5.48%, has turned activist shareholder and is pushing ...

These 27 stocks can give you a more diversified portfolio than the S&P 500 — and that’s a key advantage right now

You probably already know that because of market-capitalization weighting, a broad index such as the S&P 500 SPX, -0.80% can be concentrated in a handful of stocks. Index funds are popular for goo...

Cano Health Stock Plumments on Report CVS Is Abandoning Purchase

Cano Health shares had their largest drop on record Monday following a report that CVS Health has walked away from a potential acquisition of the primary care provider. Dealreporter was the first to r...

Tesla, Netflix Set to Report Earnings as Recession Talk Mounts

Procter & Gamble Netflix and Tesla highlight a busy coming week of earnings as persistent inflation and climbing interest rates stoke talk of a recession. Consumer healthcare giant Johnson & J...

Tesla, Goldman Sachs, Netflix, AT&T, and Other Stocks for Investors to Watch This Week

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

Moderna Stock Takes Off on Cancer Vaccine News

Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...

Chipotle Stock Could Heat Up. Here Comes a Speedy Robo Burrito Maker.

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...